• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名同时接受血液透析和华法林治疗的患者出现血管钙化和钙化防御。

Vascular calcifications and calciphylaxis in a patient on concurrent haemodialysis and Coumadin therapy.

作者信息

Schnur Jack, Sinawe Hadeer, Yoham Athina Lidia, Casadesus Damian

机构信息

Internal Medicine, Jackson Memorial Hospital, Miami, Florida, USA.

Internal Medicine, Jackson Memorial Hospital, Miami, Florida, USA

出版信息

BMJ Case Rep. 2021 Mar 24;14(3):e240310. doi: 10.1136/bcr-2020-240310.

DOI:10.1136/bcr-2020-240310
PMID:33762282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7993223/
Abstract

Calciphylaxis is a rare life-threatening condition, with calcification of small and medium-sized vessels leading to skin necrosis. It has a high morbidity and mortality, and most of the patients die from wound superinfection and sepsis. A 48-year-old man with a history of end-stage renal disease on haemodialysis and Coumadin therapy for venous thromboembolism presented with pulmonary oedema after missing two haemodialysis treatment. At examination, he had bilateral lower extremity dark brown, possibly necrotic, painful ulcers. He was diagnosed with calciphylaxis and treated with sevelamer hydrochloride, low calcium dialysate and sodium thiosulfate with haemodialysis. He received daily wound care with topical collagenase. After daily wound care treatment for 4 months, the patient's ulcers completely healed. The patient had been followed for 8 months, which included 29 additional readmissions, 3 admissions related to bacteraemia and 26 admissions with the diagnosis of pulmonary oedema and hyperkalaemia requiring haemodialysis.

摘要

钙过敏是一种罕见的危及生命的疾病,中小血管钙化导致皮肤坏死。其发病率和死亡率很高,大多数患者死于伤口超级感染和败血症。一名48岁男性,有终末期肾病病史,正在接受血液透析,并因静脉血栓栓塞接受华法林治疗,在错过两次血液透析治疗后出现肺水肿。检查时,他双侧下肢有暗褐色、可能坏死的疼痛性溃疡。他被诊断为钙过敏,并接受了盐酸司维拉姆、低钙透析液和硫代硫酸钠血液透析治疗。他每天接受外用胶原酶伤口护理。经过4个月的每日伤口护理治疗,患者的溃疡完全愈合。该患者已随访8个月,期间另有29次入院,3次与菌血症有关,26次因诊断为肺水肿和高钾血症需要血液透析而入院。

相似文献

1
Vascular calcifications and calciphylaxis in a patient on concurrent haemodialysis and Coumadin therapy.一名同时接受血液透析和华法林治疗的患者出现血管钙化和钙化防御。
BMJ Case Rep. 2021 Mar 24;14(3):e240310. doi: 10.1136/bcr-2020-240310.
2
Penile calciphylaxis in a patient with concurrent haemodialysis and Coumadin treatment.并发血液透析和华法林治疗的患者发生阴茎钙化防御。
BMJ Case Rep. 2023 May 2;16(5):e254925. doi: 10.1136/bcr-2023-254925.
3
[Calcific uremic arteriolopathy - treatment with sodium thiosulfate].[钙化性尿毒症小动脉病——硫代硫酸钠治疗]
Vnitr Lek. 2015 Feb;61(2):166-72.
4
Calciphylaxis after parathyroidectomy.甲状旁腺切除术后的钙化防御。
Hemodial Int. 2017 Oct;21 Suppl 2:S62-S66. doi: 10.1111/hdi.12599.
5
[Calciphylaxis, a life-threatening condition in dialysis patients].[钙过敏,一种透析患者的危及生命的病症]
Ned Tijdschr Geneeskd. 2022 Jan 18;166:D6379.
6
The Multifactorial Pathogenesis of Calciphylaxis: A Case Report.钙化防御的多因素发病机制:1 例报告。
Am J Case Rep. 2021 Jun 7;22:e930026. doi: 10.12659/AJCR.930026.
7
Calciphylaxis of the penis and distal digits: a case report.阴茎和远端指(趾)calciphylaxis:病例报告。
J Med Case Rep. 2022 Jan 18;16(1):18. doi: 10.1186/s13256-021-03231-4.
8
Complete resolution of recurrent calciphylaxis with long-term intravenous sodium thiosulfate.长期静脉注射硫代硫酸钠使复发性钙化防御完全消退。
Australas J Dermatol. 2008 Feb;49(1):30-4. doi: 10.1111/j.1440-0960.2007.00416.x.
9
Painful skin lesion in a patient on haemodialysis: a diagnosis not to miss.血液透析患者出现皮肤痛性皮损:不容忽视的诊断。
BMJ Case Rep. 2021 Nov 2;14(11):e245323. doi: 10.1136/bcr-2021-245323.
10
Calciphylaxis and nonhealing wounds: the role of the vascular surgeon in a multidisciplinary treatment.钙过敏症与难愈合伤口:血管外科医生在多学科治疗中的作用
J Vasc Surg. 2003 Mar;37(3):501-7. doi: 10.1067/mva.2003.70.

本文引用的文献

1
Review: update on the management of calciphylaxis.综述:钙化防御的治疗进展。
QJM. 2019 Jan 1;112(1):29-34. doi: 10.1093/qjmed/hcy234.
2
Calciphylaxis.钙过敏症
N Engl J Med. 2018 May 3;378(18):1704-1714. doi: 10.1056/NEJMra1505292.
3
Warfarin-induced calciphylaxis.华法林所致钙化防御。
BMJ Case Rep. 2016 Jan 18;2016:bcr2015214142. doi: 10.1136/bcr-2015-214142.
4
Successful treatment of calciphylaxis by a multidisciplinary approach.采用多学科方法成功治疗钙过敏症。
BMJ Case Rep. 2014 Jul 17;2014:bcr2014204354. doi: 10.1136/bcr-2014-204354.
5
Regression of vascular calcification following an acute episode of calciphylaxis: a case report.钙化防御急性发作后血管钙化的消退:一例报告
J Med Case Rep. 2014 Feb 14;8:52. doi: 10.1186/1752-1947-8-52.
6
Warfarin and calcific uremic arteriolopathy.华法林与钙化性尿毒症小动脉病
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.06.2008.0126. Epub 2009 Dec 3.
7
Early stages of calciphylaxis: are skin biopsies the answer?钙过敏的早期阶段:皮肤活检是答案吗?
Case Rep Dermatol. 2011 Sep;3(3):201-5. doi: 10.1159/000333007. Epub 2011 Sep 23.
8
Calciphylaxis: a systematic review of existing and emerging therapies.钙化防御:现有和新兴疗法的系统评价。
J Am Acad Dermatol. 2012 Dec;67(6):e253-60. doi: 10.1016/j.jaad.2011.06.009. Epub 2011 Aug 6.
9
Calciphylaxis: natural history, risk factor analysis, and outcome.钙过敏症:自然病史、危险因素分析及预后
J Am Acad Dermatol. 2007 Apr;56(4):569-79. doi: 10.1016/j.jaad.2006.08.065. Epub 2006 Dec 1.
10
Calciphylaxis in a patient with end-stage renal disease.
J Dermatol. 2001 May;28(5):272-5. doi: 10.1111/j.1346-8138.2001.tb00131.x.